3,000 Shares in HCA Healthcare, Inc. (NYSE:HCA) Bought by Ally Financial Inc.

Ally Financial Inc. bought a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 3,000 shares of the company's stock, valued at approximately $900,000.

Several other hedge funds have also recently bought and sold shares of HCA. Sanders Capital LLC increased its position in shares of HCA Healthcare by 1.0% during the 4th quarter. Sanders Capital LLC now owns 11,655,563 shares of the company's stock valued at $3,498,417,000 after purchasing an additional 116,826 shares during the period. First Eagle Investment Management LLC raised its holdings in shares of HCA Healthcare by 0.5% during the fourth quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company's stock valued at $1,351,830,000 after acquiring an additional 23,177 shares during the period. Geode Capital Management LLC boosted its holdings in shares of HCA Healthcare by 1.3% during the fourth quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company's stock worth $1,159,882,000 after purchasing an additional 50,321 shares during the period. Norges Bank purchased a new stake in shares of HCA Healthcare during the 4th quarter worth about $840,286,000. Finally, Franklin Resources Inc. increased its position in HCA Healthcare by 11.7% during the third quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company's stock worth $660,842,000 after buying an additional 174,946 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have recently weighed in on HCA. Royal Bank of Canada reduced their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating for the company in a research note on Monday, January 27th. Truist Financial decreased their target price on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research note on Monday, January 6th. KeyCorp cut their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating for the company in a research report on Tuesday, January 7th. Cantor Fitzgerald reiterated an "overweight" rating and issued a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. Finally, Bank of America cut their target price on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $381.67.

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.30% of the stock is owned by corporate insiders.

HCA Healthcare Trading Up 1.5 %

HCA traded up $4.89 during mid-day trading on Tuesday, reaching $322.50. The stock had a trading volume of 579,775 shares, compared to its average volume of 1,382,204. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The firm's fifty day simple moving average is $328.66 and its two-hundred day simple moving average is $333.19. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The stock has a market capitalization of $79.40 billion, a P/E ratio of 14.68, a P/E/G ratio of 1.10 and a beta of 1.48.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the business posted $5.90 earnings per share. On average, equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were paid a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.89%. The ex-dividend date of this dividend was Monday, March 17th. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. HCA Healthcare's dividend payout ratio is presently 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.